Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: Incidence, risk factors, and outcomes

Hematology/ Oncology and Stem Cell Therapy

Volumn 4, Issue 2, 2011, Pages 67-72

  Al Hajjar, Sami ^a,b   Al Seraihi, Amal ^a   Al Muhsen, Saleh ^a,b   Ayas, Mouhab ^a   Al Jumaah, Suliman ^a   Al Jefri, Abdullah ^a   Shoukri, Mohamed ^a   El Solh, Hassan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CORTICOSTEROID; FLUCONAZOLE; VIRUS ANTIGEN;

AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; ONSET AGE; OUTCOME ASSESSMENT; PNEUMONIA; PRESCHOOL CHILD; RETINITIS; SCHOOL CHILD; UNRELATED CORD BLOOD TRANSPLANTATION; VIREMIA; VIRUS REACTIVATION;

EID: 79960993175     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.5144/1658-3876.2011.67     Document Type: Article

References (34)

1. Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A. Locatelli, F. et al. Comparison of outcome of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97, 2962-2971.
2. Boeckh M, Nichols WG, papanicolaou G, et al. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol blood marrow Transplant. 2003; 9: 543-558.
3. Zaia JA. prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. Clin infect Dis. 2002; 5: 999-1004.
4. Brown JA, Boussiotis vA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin immunol. 2008; 127: 286-297.
5. Einsele H, Hebart H, Kauffmann-Schneider C, et al. Risk factors for treatment failures in patients receiving pCR-based pre-emptive therapy for CMv infection.
6. Ljungman P, Perez-Bercoff l, Jonsson J, et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematogica 2006; 91(1): 78-83.
7. Marty FM, Bryar J, Browne St, et al. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogenic hematopietic stem cell transplantation: a cohort analysis. Blood 2007; 110(2): 490-500.
8. Walker CM, van burik JA, De For TE, et al. Cytomegalovirus infection after allogeniic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol blood Marrow Transplant 2007; (13(9): 1106-15.
9. Lungman P, Hakki M, Boeck M, Cytomegalovirus in Hematopoietic stem cell transplants recipients. infect Dis Clin N Am 2010; 24: 319-337.
10. Beck JC, Wagner JE, Defor TE, Brenstein CG, Schleiss NR, Young Jo, Anne et al. impact of Cytomegalovirus reactivation after umbilical cord blood transplantation. Bid Blood Marrow Transplant 2010; 2: 215-22
11. Al-Seraihi A. Unrelated cord blood transplantation in pediatric patients. The experience of the King Faisal Specialist Hospital and Research Center. bone Marrow Transplant 2008: (Supp 1): 564-65.
12. Ayas M, Al Jefri A, Al Ahmari A, Al MAhr M, Al Ghonaium A, Al Mouhsen S, et al. Unrelated Cord Blood Transplantation in pediatric patients: A report from Saudi Arabia. Bone mArrow Transplant. 2009; doi: 10.1038/bmt: 2009-350.
13. Gault, E., Y. Michael, A. Dehee, C. Belabani, J.C. Nicolas, and A. Garbarg-Chenon. Quantification of human cytomegalovirus DNA by real-time pCR. J. Clin. Microbiol, 2001; 39: 772-775.
14. Gor, D., C. Sabin, H.G. prentice, N. Vyas, S. Man, p. D. Griffiths, et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak load, donor/recipient serostatus, acute GvHD and CMv disease. Bone Marrow Transplant, 1998; 21: 597-605.
15. Ville ML, Quachee M, Sanget AS, Blanche S, Buzyn A, Rouzious C. Monitoring Cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real time pCR assay performed with blood plasma. JCM 2003; 41(5): 2040-2045.
16. Boekh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004; 103: 2003-2008.
17. Matsumura T, Narimatsu H, Kami M, Tuji K, Kusumi E, Hori A., et al. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. ASBMT 2007; 13: 577-583.
18. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980; 69204-217.
19. Pumannova M, Roubalova K, Vitek A, et al. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring stem cell transplantation. Diagn Microbial infect Dis. 2006; 54: 115-120.
20. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin infect Dis. 2002; 34: 1094-1097.
21. Gray RJ. A class of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1141-1154.
22. Brown JA, Stevenson K, Kim HT, Cutler C, Baller K, McDonough S, et al. Clearance of CMV viremia after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. Blood 2010; 115(20): 4111-19.
23. Wingard JR, Chen DY, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW: Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988: 7; 1432-7.
24. Reusser P: Cytomegalovirus infection and disease after bone marrow transplantation: epidemiology, prevention and treatment. Bone Marrow Transplant 52, 1991; 7(Supp (3); 52.
25. Mylonakis E, Kallas WM, Fishman JA. Combination antiviral therapy for Ganciclovir resistant Cytomegalovirus infection in Solid-organ transplant recipients. CID 2002; 34: 1337-41.
26. Krause H., Hebart H., Jahn G, Mueller CA, Einsele H: Screening for CMV specific T cell proliferation to indentify patients at risk of developing late onset CMV disease. Bone Marrow Transplant 1997: 19; 1111-6.
27. Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101: 407-14.
28. Yoo KH, Lee SH, Sungk w, et al. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol. 2011; 86(1): 12-17.
29. Takami A, Mochizukik, Asakura H, et al. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant haematologica 2005; 90: 1290-1292.
30. Saavedra S, Sanjo F, Jarque i, et al. Early infection in adult patient undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 2002; 30(12); 937-943.
31. Montesimos P, Sanz J, Cantero, et al. incidence, Risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis valganciclovir or intravenous ganciclovic after umbilicus cord blood transplantation. Biol Blood Marrow Transplant 2009; 15: 730-740.
32. Genera G, LLeri D, Zecca M, et al. Rising antigenenia level may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogenic hematopoietic stem cell transplant receipients. Hematologica 2005; 90: 526-533.
33. Solano C, Navarro D, Clinical virology of cytomegalovirus infection following hematopoietic transplantation. Future Virology, 2010 3(1): 111-124.
34. Perales MA. Adoptive therapy of cytomegalovirus specific T Lymphocytes: is less More? Clin infect Dis. 2011; 52(1): 58-60.